ASC Biosciences, Inc. announced that it has entered into letter of intent with new investor, Stem Cell Development Fund, LLC for a private placement on best effort basis of 800,000 shares at a price of $1.93 per share for gross proceeds of $1,544,000 on June 8, 2017. The company will receive first tranche on June 12, 2017. The company will issue shares from its treasury.